Versant Capital Management’s Astera Labs ALAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ALAB
Versant Capital Management's ALAB Position: Q3 2026 in Review
Versant Capital Management reduced its Astera Labs (ALAB) stake by 7.7% in Q3 2026, selling an estimated $10K and leaving 371 shares worth $132K. The position accounts for 0.01% of the portfolio, ranked #802.
Versant Capital Management first reported a position in ALAB in Q1 2025 and has held it in 7 quarters since. The position peaked at $194K in Q2 2026. 310 funds tracked by Wall St. Rank hold ALAB as of Q3 2026.
- Versant Capital Management held 371 shares of Astera Labs worth $132K as of Q3 2026.
- Versant Capital Management sold 31 Astera Labs shares in Q3 2026, an estimated $10K.
- Astera Labs made up 0.01% of Versant Capital Management's portfolio in Q3 2026, its #802 holding.
- Versant Capital Management first reported a position in Astera Labs in Q1 2025 and has held it in 7 quarters since.
- Versant Capital Management's Astera Labs position peaked at $194K in Q2 2026.
- 310 funds tracked by Wall St. Rank held Astera Labs as of Q3 2026.
Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.